Heparin enhances the furin cleavage of HIV-1 gp160 peptides

被引:23
|
作者
Pasquato, A. [1 ,2 ]
Dettin, M. [2 ]
Basak, A. [3 ]
Gambaretto, R. [2 ]
Tonin, L. [2 ]
Seidah, N. G. [1 ]
Di Bello, C. [2 ]
机构
[1] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada
[2] Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy
[3] Ottawa Hlth Res Inst, Dis Aging Program, Reg Protein Chem Ctr, Ottawa, ON K1Y 4E9, Canada
基金
加拿大健康研究院;
关键词
HIV-1; furin; heparin; glycosaminoglycan; gp160; processing;
D O I
10.1016/j.febslet.2007.11.050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infectious HIV-1 requires gp160 cleavage by furin at the REKR511 down arrow motif (site1) into the gp120/gp41 complex, whereas the KAKR(503) (site2) sequence remains uncleaved. We synthesized 41mer and 51mer peptides, comprising site1 and site2, to study their conformation and in vitro furin processing. We found that, while the previously reported 19mer and 13mer analogues represent excellent in vitro furin substrates, the present extended sequences require heparin for optimal processing. Our data support the hypothesis of a direct binding of heparin with site1 and site2, allowing selective exposure/accessibility of the REKR sequence, which is only then optimally cleaved by furin. (C) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:5807 / 5813
页数:7
相关论文
共 50 条
  • [1] FURIN IS IMPORTANT BUT NOT ESSENTIAL FOR THE PROTEOLYTIC MATURATION OF GP160 OF HIV-1
    GU, ML
    RAPPAPORT, J
    LEPPLA, SH
    [J]. FEBS LETTERS, 1995, 365 (01) : 95 - 97
  • [2] Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site
    Oliva, R
    Leone, M
    Falcigno, L
    D'Auria, G
    Dettin, M
    Scarinci, C
    Di Bello, C
    Paolillo, L
    [J]. CHEMISTRY-A EUROPEAN JOURNAL, 2002, 8 (06) : 1467 - 1473
  • [3] Immunisation with gp160 in HIV-1 infection
    Flala, C
    Stewart, GT
    [J]. LANCET, 1999, 354 (9182): : 948 - 948
  • [4] Immunisation with gp160 in HIV-1 infection -: Reply
    Sandstöm, EG
    Wahren, B
    [J]. LANCET, 1999, 354 (9182): : 949 - 949
  • [5] COMPLEMENT ACTIVATION BY GP160 GLYCOPROTEIN OF HIV-1
    THIEBLEMONT, N
    HAEFFNERCAVAILLON, N
    WEISS, L
    MAILLET, F
    KAZATCHKINE, MD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (03) : 229 - 233
  • [6] INHIBITION OF FURIN-MEDIATED CLEAVAGE ACTIVATION OF HIV-1 GLYCOPROTEIN-GP160
    HALLENBERGER, S
    BOSCH, V
    ANGLIKER, H
    SHAW, E
    KLENK, HD
    GARTEN, W
    [J]. NATURE, 1992, 360 (6402) : 358 - 361
  • [7] STRUCTURAL INVESTIGATION AND KINETIC CHARACTERIZATION OF POTENTIAL CLEAVAGE SITES OF HIV GP160 BY HUMAN FURIN AND PC1
    BRAKCH, N
    DETTIN, M
    SCARINCI, C
    SEIDAH, NG
    DIBELLO, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 213 (01) : 356 - 361
  • [8] HIV-1 gp160 induces alterations in ion transport
    Comardelle, AM
    Gatti, PJ
    Plymale, DR
    Choi, BK
    Norris, CH
    Fermin, CD
    Beary, TP
    Tencza, SB
    Montelaro, RC
    Garry, RF
    [J]. FASEB JOURNAL, 1997, 11 (03): : 3091 - 3091
  • [9] SYNTHESIS AND PROCESSING OF HIV-1 GP160 IN CELLS WITH DEFECTIVE HIV-1 GENOMES
    KALYANARAMAN, VS
    RODRIGUEZ, V
    GALLO, RC
    SARNGADHARAN, MG
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 197 - 197
  • [10] Dendronized Gold Nanoparticles as Carriers for gp160 (HIV-1) Peptides: Biophysical Insight into Complex Formation
    Garaiova, Zuzana
    Melikishvili, Sopio
    Michlewska, Sylwia
    Ionov, Maksim
    Pedziwiatr-Werbicka, Elzbieta
    Waczulikova, Iveta
    Hianik, Tibor
    Gomez-Ramirez, Rafael
    de la Mata, Francisco Javier
    Bryszewska, Maria
    [J]. LANGMUIR, 2021, 37 (04) : 1542 - 1550